Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis

Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis

To examine both predictive and clinicopathological importance underlying in malignant tumors, our study adopts meta-analysis. We searched from PubMed, Embase, WOS, Wanfang and CNKI. Stata SE15.1 was used to calculate the risk ratio (HR) as well as relative risk (RR) with 95% of overall CIs to assess...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future science OA 2024-01, Vol.10 (1), p.FSO901-FSO901
Hauptverfasser: Liu, Xiaohan, Min, Shengyun, Zhang, Qin, Liu, Yan, Zou, Zhenhong, Wang, Nanye, Zhou, Bin
Format: Artikel
Sprache:eng
Schlagworte:
biomarkers
cancer
FOXD1
meta-analysis
prognosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To examine both predictive and clinicopathological importance underlying in malignant tumors, our study adopts meta-analysis. We searched from PubMed, Embase, WOS, Wanfang and CNKI. Stata SE15.1 was used to calculate the risk ratio (HR) as well as relative risk (RR) with 95% of overall CIs to assess FOXD1 and overall survival rate (OS), disease-free survival rate as well as clinicopathological parameters. 3808 individuals throughout 17 trials showed high FOXD1 expression was linked to disadvantaged OS (p 
ISSN:2056-5623
2056-5623
DOI:10.2144/fsoa-2023-0085